Transesophageal Echocardiography (TEE) stands out as a sophisticated medical imaging method designed to offer detailed insights into the heart's intricacies through the use of high-frequency sound waves. In contrast to conventional echocardiography, TEE involves the insertion of a small ultrasound transducer into the esophagus, enabling a closer and clearer visualization of the heart's structures. This technique becomes particularly valuable when a more thorough examination of the heart is warranted, especially in cases involving ambiguous or intricate cardiac conditions. The versatility of TEE becomes evident in its ability to assess heart valve function with precision, identify the presence of blood clots or masses within the heart chambers, and provide a comprehensive evaluation of the heart's overall anatomy. This imaging modality finds frequent application in surgical settings, notably during cardiac surgeries, where it serves as an invaluable tool to guide surgeons in executing precise interventions. By offering real-time and high-resolution images, TEE contributes significantly to enhancing the accuracy of surgical procedures and decision-making processes.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation